Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury

Akito Shimouchi, Harumasa Yokota, Shinji Ono, Chiemi Matsumoto, Toshihiro Tamai, Hiroko Takumi, Subbadra P. Narayanan, Shoji Kimura, Hiroya Kobayashi, Ruth B. Caldwell, Taiji Nagaoka, Akitoshi Yoshida

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: To determine whether water-dispersible hesperetin (WD-Hpt) can prevent degeneration of ganglion cell neurons in the ischemic retina. Methods: Ischemia reperfusion (I/R) injury was induced by increasing the intraocular pressure of mice to 110 mmHg for 40 min. Mice received daily intraperitoneal injections with either normal saline (NS, 0.3 ml/day) or WD-Hpt (0.3 ml, 200 mg/kg/day). Reactive oxygen species (ROS) was assessed by dihydroethidium and nitrotyrosine formation. Inflammation was estimated by microglial morphology in the retina. Lipopolysaccharide (LPS)-stimulated BV-2 cells were used to explore the anti-inflammatory effect of WD-Hpt on activated microglia by quantifying the expression of IL-1β using real-time quantitative reverse transcription-polymerase chain reaction. Ganglion cell loss was assessed by immunohistochemistry of NeuN. Glial activation was quantified with glial fibrillary acidic protein (GFAP) immunoreactivity. Apoptosis was evaluated with a terminal deoxynucleotidyl transferase (TUNEL) assay and immunohistochemistry of cleaved caspase-3. Phosphorylation of extracellular signal-regulated kinase (p-ERK) was surveyed by western blotting. Results: WD-Hpt decreased I/R-induced ROS formation. WD-Hpt alleviated microglial activation induced by I/R and reduced mRNA levels of IL-1β in LPS-stimulated BV-2. I/R resulted in a 37 % reduction in the number of ganglion cells in the NS-treated mice, whereas the reduction was only 5 % in the WD-Hpt-treated mice. In addition, WD-Hpt mitigated the immunoreactivity of GFAP, increased expression of cleaved caspase-3, increased number of TUNEL positive cells and p-ERK after I/R. Conclusions: WD-Hpt protected ganglion cells from I/R injury by inhibiting oxidative stress and modulating cell death signaling. Moreover, WD-Hpt had an anti-inflammatory effect through the suppression of activated microglia.

Original languageEnglish (US)
Pages (from-to)51-61
Number of pages11
JournalJapanese Journal of Ophthalmology
Volume60
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Neuroprotective Agents
Reperfusion Injury
Water
Ganglia
Reperfusion
Ischemia
Glial Fibrillary Acidic Protein
Extracellular Signal-Regulated MAP Kinases
In Situ Nick-End Labeling
Microglia
Interleukin-1
Caspase 3
Lipopolysaccharides
Retina
Reactive Oxygen Species
Anti-Inflammatory Agents
Immunohistochemistry
Phosphorylation
hesperetin
DNA Nucleotidylexotransferase

Keywords

  • Hesperetin
  • Inflammation
  • Ischemia–reperfusion
  • Neuroprotection
  • Retina

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Shimouchi, A., Yokota, H., Ono, S., Matsumoto, C., Tamai, T., Takumi, H., ... Yoshida, A. (2016). Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury. Japanese Journal of Ophthalmology, 60(1), 51-61. https://doi.org/10.1007/s10384-015-0415-z

Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury. / Shimouchi, Akito; Yokota, Harumasa; Ono, Shinji; Matsumoto, Chiemi; Tamai, Toshihiro; Takumi, Hiroko; Narayanan, Subbadra P.; Kimura, Shoji; Kobayashi, Hiroya; Caldwell, Ruth B.; Nagaoka, Taiji; Yoshida, Akitoshi.

In: Japanese Journal of Ophthalmology, Vol. 60, No. 1, 01.01.2016, p. 51-61.

Research output: Contribution to journalArticle

Shimouchi, A, Yokota, H, Ono, S, Matsumoto, C, Tamai, T, Takumi, H, Narayanan, SP, Kimura, S, Kobayashi, H, Caldwell, RB, Nagaoka, T & Yoshida, A 2016, 'Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury', Japanese Journal of Ophthalmology, vol. 60, no. 1, pp. 51-61. https://doi.org/10.1007/s10384-015-0415-z
Shimouchi, Akito ; Yokota, Harumasa ; Ono, Shinji ; Matsumoto, Chiemi ; Tamai, Toshihiro ; Takumi, Hiroko ; Narayanan, Subbadra P. ; Kimura, Shoji ; Kobayashi, Hiroya ; Caldwell, Ruth B. ; Nagaoka, Taiji ; Yoshida, Akitoshi. / Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury. In: Japanese Journal of Ophthalmology. 2016 ; Vol. 60, No. 1. pp. 51-61.
@article{ebe087d270ae48d98e7c89931a5b46d8,
title = "Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury",
abstract = "Purpose: To determine whether water-dispersible hesperetin (WD-Hpt) can prevent degeneration of ganglion cell neurons in the ischemic retina. Methods: Ischemia reperfusion (I/R) injury was induced by increasing the intraocular pressure of mice to 110 mmHg for 40 min. Mice received daily intraperitoneal injections with either normal saline (NS, 0.3 ml/day) or WD-Hpt (0.3 ml, 200 mg/kg/day). Reactive oxygen species (ROS) was assessed by dihydroethidium and nitrotyrosine formation. Inflammation was estimated by microglial morphology in the retina. Lipopolysaccharide (LPS)-stimulated BV-2 cells were used to explore the anti-inflammatory effect of WD-Hpt on activated microglia by quantifying the expression of IL-1β using real-time quantitative reverse transcription-polymerase chain reaction. Ganglion cell loss was assessed by immunohistochemistry of NeuN. Glial activation was quantified with glial fibrillary acidic protein (GFAP) immunoreactivity. Apoptosis was evaluated with a terminal deoxynucleotidyl transferase (TUNEL) assay and immunohistochemistry of cleaved caspase-3. Phosphorylation of extracellular signal-regulated kinase (p-ERK) was surveyed by western blotting. Results: WD-Hpt decreased I/R-induced ROS formation. WD-Hpt alleviated microglial activation induced by I/R and reduced mRNA levels of IL-1β in LPS-stimulated BV-2. I/R resulted in a 37 {\%} reduction in the number of ganglion cells in the NS-treated mice, whereas the reduction was only 5 {\%} in the WD-Hpt-treated mice. In addition, WD-Hpt mitigated the immunoreactivity of GFAP, increased expression of cleaved caspase-3, increased number of TUNEL positive cells and p-ERK after I/R. Conclusions: WD-Hpt protected ganglion cells from I/R injury by inhibiting oxidative stress and modulating cell death signaling. Moreover, WD-Hpt had an anti-inflammatory effect through the suppression of activated microglia.",
keywords = "Hesperetin, Inflammation, Ischemia–reperfusion, Neuroprotection, Retina",
author = "Akito Shimouchi and Harumasa Yokota and Shinji Ono and Chiemi Matsumoto and Toshihiro Tamai and Hiroko Takumi and Narayanan, {Subbadra P.} and Shoji Kimura and Hiroya Kobayashi and Caldwell, {Ruth B.} and Taiji Nagaoka and Akitoshi Yoshida",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s10384-015-0415-z",
language = "English (US)",
volume = "60",
pages = "51--61",
journal = "Japanese Journal of Ophthalmology",
issn = "0021-5155",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury

AU - Shimouchi, Akito

AU - Yokota, Harumasa

AU - Ono, Shinji

AU - Matsumoto, Chiemi

AU - Tamai, Toshihiro

AU - Takumi, Hiroko

AU - Narayanan, Subbadra P.

AU - Kimura, Shoji

AU - Kobayashi, Hiroya

AU - Caldwell, Ruth B.

AU - Nagaoka, Taiji

AU - Yoshida, Akitoshi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose: To determine whether water-dispersible hesperetin (WD-Hpt) can prevent degeneration of ganglion cell neurons in the ischemic retina. Methods: Ischemia reperfusion (I/R) injury was induced by increasing the intraocular pressure of mice to 110 mmHg for 40 min. Mice received daily intraperitoneal injections with either normal saline (NS, 0.3 ml/day) or WD-Hpt (0.3 ml, 200 mg/kg/day). Reactive oxygen species (ROS) was assessed by dihydroethidium and nitrotyrosine formation. Inflammation was estimated by microglial morphology in the retina. Lipopolysaccharide (LPS)-stimulated BV-2 cells were used to explore the anti-inflammatory effect of WD-Hpt on activated microglia by quantifying the expression of IL-1β using real-time quantitative reverse transcription-polymerase chain reaction. Ganglion cell loss was assessed by immunohistochemistry of NeuN. Glial activation was quantified with glial fibrillary acidic protein (GFAP) immunoreactivity. Apoptosis was evaluated with a terminal deoxynucleotidyl transferase (TUNEL) assay and immunohistochemistry of cleaved caspase-3. Phosphorylation of extracellular signal-regulated kinase (p-ERK) was surveyed by western blotting. Results: WD-Hpt decreased I/R-induced ROS formation. WD-Hpt alleviated microglial activation induced by I/R and reduced mRNA levels of IL-1β in LPS-stimulated BV-2. I/R resulted in a 37 % reduction in the number of ganglion cells in the NS-treated mice, whereas the reduction was only 5 % in the WD-Hpt-treated mice. In addition, WD-Hpt mitigated the immunoreactivity of GFAP, increased expression of cleaved caspase-3, increased number of TUNEL positive cells and p-ERK after I/R. Conclusions: WD-Hpt protected ganglion cells from I/R injury by inhibiting oxidative stress and modulating cell death signaling. Moreover, WD-Hpt had an anti-inflammatory effect through the suppression of activated microglia.

AB - Purpose: To determine whether water-dispersible hesperetin (WD-Hpt) can prevent degeneration of ganglion cell neurons in the ischemic retina. Methods: Ischemia reperfusion (I/R) injury was induced by increasing the intraocular pressure of mice to 110 mmHg for 40 min. Mice received daily intraperitoneal injections with either normal saline (NS, 0.3 ml/day) or WD-Hpt (0.3 ml, 200 mg/kg/day). Reactive oxygen species (ROS) was assessed by dihydroethidium and nitrotyrosine formation. Inflammation was estimated by microglial morphology in the retina. Lipopolysaccharide (LPS)-stimulated BV-2 cells were used to explore the anti-inflammatory effect of WD-Hpt on activated microglia by quantifying the expression of IL-1β using real-time quantitative reverse transcription-polymerase chain reaction. Ganglion cell loss was assessed by immunohistochemistry of NeuN. Glial activation was quantified with glial fibrillary acidic protein (GFAP) immunoreactivity. Apoptosis was evaluated with a terminal deoxynucleotidyl transferase (TUNEL) assay and immunohistochemistry of cleaved caspase-3. Phosphorylation of extracellular signal-regulated kinase (p-ERK) was surveyed by western blotting. Results: WD-Hpt decreased I/R-induced ROS formation. WD-Hpt alleviated microglial activation induced by I/R and reduced mRNA levels of IL-1β in LPS-stimulated BV-2. I/R resulted in a 37 % reduction in the number of ganglion cells in the NS-treated mice, whereas the reduction was only 5 % in the WD-Hpt-treated mice. In addition, WD-Hpt mitigated the immunoreactivity of GFAP, increased expression of cleaved caspase-3, increased number of TUNEL positive cells and p-ERK after I/R. Conclusions: WD-Hpt protected ganglion cells from I/R injury by inhibiting oxidative stress and modulating cell death signaling. Moreover, WD-Hpt had an anti-inflammatory effect through the suppression of activated microglia.

KW - Hesperetin

KW - Inflammation

KW - Ischemia–reperfusion

KW - Neuroprotection

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=84954392961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954392961&partnerID=8YFLogxK

U2 - 10.1007/s10384-015-0415-z

DO - 10.1007/s10384-015-0415-z

M3 - Article

C2 - 26407617

AN - SCOPUS:84954392961

VL - 60

SP - 51

EP - 61

JO - Japanese Journal of Ophthalmology

JF - Japanese Journal of Ophthalmology

SN - 0021-5155

IS - 1

ER -